Characterization of J wave in a patient with idiopathic ventricular fibrillation

Heart Rhythm

Volumn 3, Issue 9, 2006, Pages 1082-1084

  Shinohara, Tetsuji ^a   Takahashi, Naohiko ^a   Saikawa, Tetsunori ^a   Yoshimatsu, Hironobu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Antiarrhythmic drugs; J wave; Ventricular fibrillation

Indexed keywords

BEPRIDIL; CILOSTAZOL; DISOPYRAMIDE; ISOPRENALINE; PROCAINAMIDE; PROPRANOLOL; VERAPAMIL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; DEFIBRILLATOR; ELECTROCARDIOGRAM; FOLLOW UP; HEART ATRIUM PACING; HEART PALPITATION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IDIOPATHIC DISEASE; MALE; PRIORITY JOURNAL; QRS COMPLEX; QT PROLONGATION; RECURRENT DISEASE; SINUS TACHYCARDIA; SYNCOPE;

ADULT; BUNDLE-BRANCH BLOCK; DEFIBRILLATORS, IMPLANTABLE; DIAGNOSIS, DIFFERENTIAL; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; EMERGENCY TREATMENT; HUMANS; MALE; VENTRICULAR FIBRILLATION;

EID: 33747822902     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2006.05.016     Document Type: Article

References (12)

1. Wever E.F., and Robles de Medina E.O. Sudden death in patients without structural heart disease. J Am Coll Cardiol 43 (2004) 1137-1144
2. Aizawa Y., Tamura M., Chinushi M., Naitoh N., Uchiyama H., Kusano Y., Hosono H., and Shibata A. Idiopathic ventricular fibrillation and bradycardia-dependent intraventricular block. Am Heart J 126 (1993) 1473-1474
3. Garg A., Finneran W., and Feld G.K. Familial sudden cardiac death associated with a terminal QRS abnormality on surface 12-lead electrocardiogram in the index case. J Cardiovasc Electrophysiol 9 (1998) 642-647
4. Yan G.X., and Antzelevitch C. Cellular basis for the electrocardiographic J wave. Circulation 93 (1996) 372-379
5. Tsunoda Y., Takeishi Y., Nozaki N., Kitahara T., and Kubota I. Presence of intermittent J waves in multiple leads in relation to episode of atrial and ventricular fibrillation. J Electrocardiol 37 (2004) 311-314
6. Shimizu W., Aiba T., and Kamakura S. Mechanisms of disease: current understanding and future challenges in Brugada syndrome. Nat Clin Pract Cardiovasc Med 2 (2005) 408-414
7. Sanchez-Chapula J.A. Mechanism of transient outward K(+) channel block by disopyramide. J Pharmacol Exp Ther 290 (1999) 515-523
8. Hlaing T., DiMino T., Kowey P.R., and Yan G.X. ECG repolarization waves: their genesis and clinical implications. Ann Noninvas Electrocardiol 10 (2005) 211-223
9. Tsuchiya T., Ashikaga K., Honda T., and Arita M. Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 13 (2002) 698-701
10. Anno T., Furuta T., Itho M., Kodama I., Toyama J., and Yamada K. Effects of bepridil on the electrophysiological properties of guinea-pig ventricular muscles. Br J Pharmacol 81 (1984) 589-597
11. Berger F., Borchard U., and Hafner D. Effects of the calcium entry blocker bepridil on repolarizing and pacemaker currents in sheep cardiac Purkinje fibres. Naunyn Schmiedebergs Arch Pharmacol 339 (1989) 638-646
12. Sugao M., Fujiki A., Nishida K., Sakabe M., Tsuneda T., Iwamoto J., Mizumaki K., and Inoue H. Repolarization dynamics in patients with idiopathic ventricular fibrillation: pharmacological therapy with bepridil and disopyramide. J Cardiovasc Pharmacol 45 (2005) 545-549